The Alteration of Autonomic Function in Multiple Organ Dysfunction Syndrome

Critical Care Clinics

Volumn 24, Issue 1, 2008, Pages 149-163

  Schmidt, Hendrik ^a   Hoyer, Dirk ^b   Wilhelm, Joachim ^a   Söffker, Gerold ^a   Heinroth, Konstantin ^a   Hottenrott, Kuno ^a   Said, Samir M ^a   Buerke, Michael ^a   Müller Werdan, Ursula ^a   Werdan, Karl ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE DISTRIBUTION; ARTIFICIAL VENTILATION; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; CHEMORECEPTOR REFLEX; CRITICAL ILLNESS; DISEASE SEVERITY; HEART RATE VARIABILITY; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SEDATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; CHEMORECEPTORS; CRITICAL CARE; HEART RATE; HUMANS; MULTIPLE ORGAN FAILURE; SEVERITY OF ILLNESS INDEX;

EID: 38649094909     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.10.003     Document Type: Review

References (68)

1. Godin P.J., and Buchman T.G. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24 (1996) 1107-1116
2. Abboud F.M., and Thames M.D. Interaction of cardiovascular reflexes in circulatory control. In: Sheperd J.T., Abboud F.M., and Geiger S.R. (Eds). Handbook of physiology. Section 2: the cardiovascular system vol. III (1983), American Physiological Society, Bethesda (MD) 675-752
3. Eyzaguirre C., Fitzgerald R.S., Lahiri S., et al. Arterial chemoreceptors. In: Sheperd J.T., Abboud F.M., and Geiger S.R. (Eds). Handbook of physiology. Section 2: the cardiovascular system vol. III (1983), American Physiological Society, Bethesda (MD) 557-562
4. Board of the European Society of Cardiology and North American Society of Pacing and Electrophysiology. Heart rate variability-standards of measurement, physiological interpretation and clinical use. Eur Heart J 17 (1996) 354-381
5. Toweill D., Sonnenthal K., Kimberley B., et al. Linear and nonlinear analysis of hemodynamic signals during sepsis and septic shock. Crit Care Med 28 (2000) 2051-2057
6. Seely A.J.E., and Christou N.V. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28 (2000) 2193-2200
7. Marshall J.C. Complexity, chaos, and incomprehensibility: parsing the biology of critical illness. Crit Care Med 28 (2000) 2646-2648
8. Haji-Michael P.G., Vincent J.L., Degaute J.P., et al. Power spectral analysis of cardiovascular variability in critically ill neurosurgical patients. Crit Care Med 28 (2000) 2578-2583
9. Stauss H.M. Heart rate variability. Am J Physiol Integr Comp Physiol 285 (2003) R927-R931
10. Taylor J.A., Deborah L.C., Myers C.W., et al. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 98 (1998) 547-555
11. Lombardi F. Chaos theory, heart rate variability and arrhythmic mortality. Circulation 101 (2000) 8-10
12. Hoyer D., Friedrich H., Stein P.K., et al. Autonomic information flow improves prognostic value of heart rate patterns after abdominal aortic surgery. Journal of Critical Care (2008) in press
13. Hoyer D., Frank B., Götze C., et al. Interactions between short-term and long-term cardiovascular control mechanisms. Chaos 17 (2007) 015110-015111 -015110-8
14. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
15. Bigger Jr. J.T., La Rovere M.T., Steinmann R.C., et al. Comparison of baroreflex sensitivity and heart rate variability after myocardial infarction. J Am Coll Cardiol 14 (1989) 1511-1518
16. Di Rienzo M., Castiglioni P., Mancia G., et al. Advancement in estimating baroreflex function. IEEE Engineering in Medicine and Biology 20 (2001) 25-32
17. Schmidt H., Heinroth K., and Werdan K. Autonomic dysfunction in critically ill patients. In: Vincent J.L. (Ed). Yearbook of intensive care and emergency medicine 1999 (1999), Springer, Berlin, Heidelberg (NY) 519-536
18. Maestri R., Pinna G.D., Mortara A.M., et al. Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques. J Am Coll Cardiol 31 (1998) 344-351
19. Pitzalis M.V., Mastropasqua F., Passantino A., et al. Comparison between noninvasive indices of baroreceptor sensitivity and the phenylephrine method in post-myocardial infarction patients. Circulation 97 (1998) 1362-1367
20. Chua T.P., Clark A.L., Amadi A.A., et al. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27 (1996) 650-657
21. Chua T.P., and Coats A.J.S. The reproducibility and comparability of tests of the peripheral chemoreflex: comparing the transient hypoxic ventilatory drive test and the single-breath carbon dioxide response test in healthy subjects. Eur J Clin Invest 25 (1995) 887-892
22. Chua T.P., Harrigton D., Ponikowski P., et al. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29 (1997) 147-152
23. Schmidt H., Rauchhaus M., Francis D.P., et al. Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence. Int J Cardiol 78 (2001) 157-165
24. Schmidt H., Werdan K., and Müller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 7 (2001) 314-322
25. Ponikowski P., and Banasiak W. Chemosensitivity in chronic heart failure. Heart Fail Monit 1 (2001) 126-131
26. Ponikowski P., Chua T.P., Piepoli M., et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96 (1997) 2586-2594
27. Ponikowski P., Chua T.P., Piepoli M., et al. Chemoreceptor dependence of very low frequency rhythms in advanced chronic heart failure. Am J Physiol 272 (1997) H438-H447
28. Hennersdorf M., Perings C., Niebich V., et al. Chemoreflex sensitivity in patients with survived sudden cardiac arrest and prior myocardial infarction. Pacing Clin Electrophysiol 23 (2000) 457-462
29. Schmidt H., Müller-Werdan U., Nuding S., et al. Impaired chemoreflex sensitivity in adult patients with Multiple Organ Dysfunction Syndrome-the potential role of disease severity. Intensive Care Med 30 (2004) 665-672
30. Hoyer D., Friedrich H., Zwiener U., et al. Prognostic impact of autonomic information in Multiple Organ Dysfunction Syndrome patients. Int J Cardiol 108 (2006) 359-369
31. Winchell R.J., and Hoyt D.B. Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. J Surg Res 63 (1996) 11-16
32. Garrard C.S., Kontoyannis D.A., and Piepoli M. Spectral analysis of heart rate variability in sepsis syndrome. Clin Auton Res 3 (1993) 5-13
33. Godin P.J., Fleisher L.A., Eidsath A., et al. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized crossover trial. Crit Care Med 24 (1996) 1117-1124
34. Schmidt H., Müller-Werdan U., Saworski J., et al. Beating rate variability of cardiomyocytes is narrowed by LPS but not by TNF-alpha. [abstract]. Intensive Care Med 25 Suppl 1 (1999) 59
35. Tibby S.M., Frndova H., Durward A., et al. Novel method to quantify loss of heart rate variability in pediatric multiple organ failure. Crit Care Med 31 (2003) 2059-2067
36. Eidelman L.A., Putterman D., Putterman C., et al. The spectrum of septic encephalopathy: definitions, etiologies, and mortalities. JAMA 275 (1996) 470-473
37. Bolton C.F., Young G.B., and Zochodne D.W. The neurological complications of sepsis. Ann Neurol 33 (1993) 94-100
38. Tobin M.J., Laghi F., and Jubran A. Respiratory muscle dysfunction in mechanically ventilated patients. Mol Cell Biochem 179 (1998) 87-98
39. Hussain S.N.A. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179 (1998) 125-134
40. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
41. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
42. Libert C. A nervous connection. Nature 421 (2003) 328-329
43. Schmidt H., Müller-Werdan U., Hoffmann T., et al. Autonomic dysfunction predicts mortality in patients with Multiple Organ Dysfunction Syndrome of different age groups. Crit Care Med 33 (2005) 1994-2002
44. Biswas A.K., Scott W.A., Sommerauer J.F., et al. Heart rate variability after acute traumatic brain injury in children. Crit Care Med 28 (2000) 3907-3912
45. Korach M., Sharshar T., Jarrin I., et al. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med 29 (2001) 1380-1385
46. Agelink M.W., Majewski T.B., Andrich J., et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam and lorazepam. Crit Care Med 30 (2002) 997-1006
47. Sellgren J., Biber B., Henriksson B.A., et al. The effects of propofol, methohexitone and isofluorane on the baroreflex in the cat. Acta Anaesthesiol Scand 36 (1992) 784-790
48. Eriksson L.I. Reduced hypoxic chemosensitivity in partially paralyzed man: a new property of muscle relaxants?. Acta Anaesthesiol Scand 40 (1996) 520-523
49. Colosimo A., Giuliani A., Mancini A.M., et al. Estimating cardiac age by means of heart rate variability. Am J Physiol 273 (1997) H1841-H1847
50. Pikkujämsä S.M., Mäkikallio T.H., Sourander L.B., et al. Cardiac interbeat interval dynamics from childhood to senescence: comparison of conventional and new measures based on fractals and chaos theory. Circulation 100 (1999) 393-399
51. Kleiger R.E., Miller J.P., Bigger J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
52. Miličević G., Lakusić N., Szirovicza L., et al. Different cut-off points of decreased heart rate variability for different age groups of cardiac patients. J Cardiovasc Risk 8 (2001) 93-102
53. Smyth H., Sleight P., and Pickering G. Reflex regulation of arterial pressure during sleep in man. Circ Res 24 (1969) 109-121
54. Schmidt H., Müller-Werdan U., Hoffmann T., et al. Attenuated autonomic function in multiple organ dysfunction syndrome across three age groups. Biomed Tech 51 (2006) 264-267
55. Sharshar T., Gray F., Lorin de la Grandmaison G., et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362 (2003) 1799-1805
56. Sharshar T., Annane D., de la Grandmaison G.L., et al. The neuropathology of septic shock. Brain Pathol 14 (2004) 21-33
57. f. Shock 28 6 (2007) 655-661
58. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure-results of the United Kingdom Heart Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 98 (1998) 1510-1516
59. Yien H.W., Hseu S.S., Lee L.C., et al. Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for prediction of patients' outcome in the intensive care unit. Crit Care Med 25 (1997) 258-266
60. Stein P.K., Schmieg R.E., El-Fouly A., et al. Association between heart rate variability recorded on postoperative day 1 and length of stay in abdominal aortic surgery patients. Crit Care Med 29 (2001) 1738-1743
61. Schmidt H., Hennen R., Keller A., et al. Association of statin therapy and increased survival in patients with Multiorgan Dysfunction Syndrome. Intensive Care Med 32 (2006) 1248-1251
62. Welzig C.M., Shin D.G., Park H.J., et al. Lipid lowering by Pravastatin increases parasympathetic modulation of heart rate: G alphai2, a possible molecular marker for parasympathetic responsiveness. Circulation 108 (2003) 2743-2746
63. Almog Y., Shefer A., Novack V., et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110 (2004) 880-885
64. Hackam D.G., Mamdani M., Li P., et al. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 367 (2006) 413-418
65. Liappis A.P., Kan V.L., Rochester C.G., et al. The effect of statins on mortality in patients with bacteraemia. Clin Infect Dis 33 (2001) 1352-1357
66. Kruger P., Fitzsimmons K., Cook D., et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 32 (2006) 75-77
67. Merx M.W., Liehn E.A., Janssens U., et al. HMG-CoA reductase inhibitor Simvastatin profoundly improves survival in a murine model of sepsis. Circulation 109 (2004) 2560-2565
68. Pruefer D., Makowski J., Schnell M., et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 106 (2002) 2104-2110